Page last updated: 2024-09-03

dehydroevodiamine and Memory Disorders

dehydroevodiamine has been researched along with Memory Disorders in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, KA; Ha, S; Jeong, YH; Kim, HJ; Kim, HS; Lee, JH; Moon, C; Noh, SJ; Park, CH; Park, HJ; Shin, KY; Suh, YH; Yoo, J	1
Hong, XP; Pan, XP; Peng, JH; Wang, JZ; Wei, W; Zhang, CE	1

Other Studies

2 other study(ies) available for dehydroevodiamine and Memory Disorders

Article	Year
Dehydroevodiamine•HCl Protects Against Memory Impairment and Cerebral Amyloid-β Production in Tg2576 Mice by Acting as a β-Secretase Inhibitor. CNS & neurological disorders drug targets, 2016, Volume: 15, Issue:8 Topics: Alkaloids; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Analysis of Variance; Animals; Avoidance Learning; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Humans; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Models, Molecular; Mutation; Neuroprotective Agents; Reaction Time	2016
Dehydroevodiamine attenuates tau hyperphosphorylation and spatial memory deficit induced by activation of glycogen synthase kinase-3 in rats. Neuropharmacology, 2007, Volume: 52, Issue:7 Topics: Alkaloids; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Gene Expression Regulation; Glycogen Synthase Kinase 3; Hippocampus; Indoles; Male; Maleimides; Memory Disorders; Phosphorylation; Rats; Rats, Wistar; tau Proteins	2007

Article

Year

Dehydroevodiamine•HCl Protects Against Memory Impairment and Cerebral Amyloid-β Production in Tg2576 Mice by Acting as a β-Secretase Inhibitor.

CNS & neurological disorders drug targets, 2016, Volume: 15, Issue:8

Topics: Alkaloids; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Analysis of Variance; Animals; Avoidance Learning; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Humans; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Models, Molecular; Mutation; Neuroprotective Agents; Reaction Time

2016

Dehydroevodiamine attenuates tau hyperphosphorylation and spatial memory deficit induced by activation of glycogen synthase kinase-3 in rats.

Neuropharmacology, 2007, Volume: 52, Issue:7

Topics: Alkaloids; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Gene Expression Regulation; Glycogen Synthase Kinase 3; Hippocampus; Indoles; Male; Maleimides; Memory Disorders; Phosphorylation; Rats; Rats, Wistar; tau Proteins

2007